Solutions For Monoclonal Antibody Manufacturing

Each stage of bioprocessing is influences by the steps preceding it. In the production of monoclonal antibodies (mAbs), manufacturing challenges such as reducing visibility, increasing yields, effective separation of impurities in downstream purification or achieving high protein concentration in formulation and drug product stability must be effectively managed in order to successfully complete regulatory review processes and bring new, life-altering medicines to the market.

As a trusted supplier for the top 20 biopharmaceutical companies, Avantor's expertise and solutions address the complexity of mAbs manufacturing. From process development and scale-up, through commercial manufacturing, we offer the products and support you need to help maintain mAbs quality, activity and stability throughout the entire process.